Chemical Formula: C12H25N5O3

Chemical Formula C12H25N5O3

Found 16 metabolite its formula value is C12H25N5O3

Arginylleucine

(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C12H25N5O3 (287.19573)

Arginylleucine is a dipeptide composed of arginine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Leucyl-Arginine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-5-carbamimidamidopentanoate

C12H25N5O3 (287.19573)

Leucyl-Arginine is a dipeptide composed of leucine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

Arginylisoleucine

(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C12H25N5O3 (287.19573)

Arginylisoleucine is a dipeptide composed of arginine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

Isoleucyl-Arginine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-5-carbamimidamidopentanoate

C12H25N5O3 (287.19573)

Isoleucyl-Arginine is a dipeptide composed of isoleucine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.